Sabra Healthcare REIT (NASDAQ:SBRA) Price Target Cut to $19.00 by Analysts at Scotiabank

Sabra Healthcare REIT (NASDAQ:SBRA) had its price objective decreased by equities research analysts at Scotiabank from $22.00 to $19.00 in a research note issued on Thursday,Benzinga reports. The firm presently has a “sector perform” rating on the real estate investment trust’s stock. Scotiabank’s price objective points to a potential upside of 5.39% from the company’s previous close.

SBRA has been the topic of several other research reports. UBS Group upped their price objective on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “neutral” rating in a report on Wednesday, May 13th. Wells Fargo & Company upped their price objective on shares of Sabra Healthcare REIT from $22.00 to $23.00 and gave the company an “overweight” rating in a report on Monday, June 1st. Cantor Fitzgerald upped their price objective on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “neutral” rating in a report on Monday, May 11th. Citizens Jmp upped their price objective on shares of Sabra Healthcare REIT from $22.00 to $23.00 and gave the company a “market outperform” rating in a report on Wednesday, February 18th. Finally, Citigroup upped their price objective on shares of Sabra Healthcare REIT from $21.00 to $24.00 and gave the company a “buy” rating in a report on Wednesday, February 18th. Five analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $22.10.

Sabra Healthcare REIT Trading Down 0.1%

SBRA stock traded down $0.02 during midday trading on Thursday, hitting $18.03. The stock had a trading volume of 1,367,179 shares, compared to its average volume of 2,594,678. The firm has a market cap of $4.55 billion, a P/E ratio of 28.66, a price-to-earnings-growth ratio of 1.38 and a beta of 0.64. The company has a current ratio of 4.72, a quick ratio of 4.72 and a debt-to-equity ratio of 0.96. Sabra Healthcare REIT has a 1-year low of $17.17 and a 1-year high of $21.28. The business has a fifty day moving average price of $19.98 and a two-hundred day moving average price of $19.67.

Sabra Healthcare REIT (NASDAQ:SBRA) last announced its quarterly earnings data on Wednesday, April 29th. The real estate investment trust reported $0.16 earnings per share for the quarter, meeting the consensus estimate of $0.16. Sabra Healthcare REIT had a net margin of 19.22% and a return on equity of 5.60%. The firm had revenue of $211.74 million for the quarter, compared to analyst estimates of $209.20 million. During the same quarter in the prior year, the business earned $0.37 earnings per share. The business’s quarterly revenue was up 20.9% compared to the same quarter last year. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. On average, sell-side analysts predict that Sabra Healthcare REIT will post 1.51 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Sabra Healthcare REIT

Institutional investors and hedge funds have recently made changes to their positions in the business. Rothschild Investment LLC raised its holdings in shares of Sabra Healthcare REIT by 164.6% in the 4th quarter. Rothschild Investment LLC now owns 1,429 shares of the real estate investment trust’s stock worth $27,000 after acquiring an additional 889 shares during the last quarter. Smartleaf Asset Management LLC raised its holdings in shares of Sabra Healthcare REIT by 97.7% in the 4th quarter. Smartleaf Asset Management LLC now owns 1,445 shares of the real estate investment trust’s stock worth $27,000 after acquiring an additional 714 shares during the last quarter. Founders Capital Management acquired a new stake in shares of Sabra Healthcare REIT in the 3rd quarter worth about $28,000. Strengthening Families & Communities LLC acquired a new stake in shares of Sabra Healthcare REIT in the 4th quarter worth about $29,000. Finally, Danske Bank A S acquired a new stake in shares of Sabra Healthcare REIT in the 3rd quarter worth about $30,000. Institutional investors and hedge funds own 99.40% of the company’s stock.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.